“Bimekizumab Versus Ustekinumab Efficacy Across Subgroups of Patients With Moderate to Severe Plaque Psoriasis: Results from the Multicenter, Randomized, Double-Blinded Phase 3 BE VIVID Trial”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 1, Jan. 2021, p. s16, https://doi.org/10.25251/skin.5.supp.16.